Immunovia AB (publ) (IMMVF) Stock Price & Growth Analysis

Quote Panel

Updated October 15, 2025

1W 0.00 % 1M -29.46 % 3M -29.46 % 1Y -29.46 %

Key Metrics

Market Cap
15.88M
Shares Outstanding
304.89M
Share in Float
284.64M
Dividende
0

Earning Date
19 Nov 2025
Price Target
0.05207
Average Volume
74.31641
Beta
2.751

Range
0.052065-0.15
Industry
Medical - Diagnostics & Research
Website
https://www.immunovia.com
Sector
Healthcare

Quote Panel

Updated October 15, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

109.48x

P/S Ratio

5.54x

P/B Ratio

0.0

Debt/Equity

-15978.3%

Net Margin

$-0.2

EPS

How IMMVF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

IMMVF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

IMMVF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$10M

350%

2026-Revenue

$0.12

73%

2026-EPS

$10M

-350%

2026-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.23

N/A

-0.08
vs -0.09

Q4.23

N/A

-0.11
vs -0.27

Q1.24

N/A

-0.01
vs -0.22

Q2.24

N/A

-0.05
vs -0.37

Q3.24

N/A

-0.11
vs -0.08

Q4.24

+102%

0
vs -0.11

Q1.25

N/A

-0.02
vs -0.01

Q2.25

N/A

NA
vs -0.05

Q3.25

N/A

-0.05
vs -0.11

Q4.25

N/A

-0.05
vs 0

Sales Growth

YoY

Current

Estimates

Q3.23

+36%

488K vs 358K

Q4.23

-69%

156K vs 502K

Q1.24

-70%

156K vs 520K

Q2.24

-79%

85K vs 412K

Q3.24

-52%

235K vs 488K

Q4.24

+192%

455K vs 156K

Q1.25

-11%

139K vs 156K

Q2.25

+6%

90K vs 85K

Q3.25

+69%

397.1K vs 235K

Q4.25

+130%

1M vs 455K

Return on Equity

QoQ

Q1.23

-28%

-0.28
vs -0.34

Q2.23

-130%

-1.30
vs -0.28

Q3.23

-41%

-0.41
vs -1.30

Q4.23

-73%

-0.73
vs -0.41

Q1.24

-7%

-0.07
vs -0.73

Q2.24

-130%

-1.30
vs -0.07

Q3.24

-132%

-1.32
vs -1.30

Q4.24

+26%

0.26
vs -1.32

Q1.25

-198%

-1.98
vs 0.26

Q2.25

-231%

-2.31
vs -1.98

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q3.23

N/A

-0.08
vs -0.09

Q4.23

N/A

-0.11
vs -0.27

Q1.24

N/A

-0.01
vs -0.22

Q2.24

N/A

-0.05
vs -0.37

Q3.24

N/A

-0.11
vs -0.08

Q4.24

+102%

0
vs -0.11

Q1.25

N/A

-0.02
vs -0.01

Q2.25

N/A

NA
vs -0.05

Q3.25

N/A

-0.05
vs -0.11

Q4.25

N/A

-0.05
vs 0

Sales Growth

YoY

Current

Estimates

Q3.23

+36%

488K vs 358K

Q4.23

-69%

156K vs 502K

Q1.24

-70%

156K vs 520K

Q2.24

-79%

85K vs 412K

Q3.24

-52%

235K vs 488K

Q4.24

+192%

455K vs 156K

Q1.25

-11%

139K vs 156K

Q2.25

+6%

90K vs 85K

Q3.25

+69%

397.1K vs 235K

Q4.25

+130%

1M vs 455K

Return on Equity

QoQ

Q1.23

-28%

-0.28
vs -0.34

Q2.23

-130%

-1.30
vs -0.28

Q3.23

-41%

-0.41
vs -1.30

Q4.23

-73%

-0.73
vs -0.41

Q1.24

-7%

-0.07
vs -0.73

Q2.24

-130%

-1.30
vs -0.07

Q3.24

-132%

-1.32
vs -1.30

Q4.24

+26%

0.26
vs -1.32

Q1.25

-198%

-1.98
vs 0.26

Q2.25

-231%

-2.31
vs -1.98

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.05USD

N/A

109.48x

5.54x

0.0

-15978.3%

$-0.2

$10M

$0.12

$10M

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

$10M

$0.12

$10M

Company Description

0.05USD

N/A

109.48x

5.54x

0.0

-15978.3%

$-0.2